Corden BioChem GmbH (CB) is a contract development and manufacturing organization of biotechnologically produced food, feed, fine chemicals and technical products. It has about 100 employees at its site in the Frankfurt Höchst Industrial Park.
CB supports its customers and their products from technology transfer, process development and optimization, through piloting and upscaling to commercial production in bioreactors with a total volume of over 3,000 m3 and corresponding large-scale downstream facilities.
CB works with customers (start-ups, SMEs, large corporations) from Germany, Europe and all over the world in all project phases and offers individual product-specific solutions. In doing so, it draws on more than 60 years of experience and extensive process know-how, as well as expertise in project management, quality, regulatory, analytics, engineering, purchasing and logistics, and an extensive network of cooperation partners.
CB is an independent company of the International Chemical Investors Group (ICIG). ICIG is a dynamically growing, globally active industrial holding in private ownership. ICIG has holdings in chemical and pharmaceutical companies with total annual sales of over 3 billion euros and more than 6,000 employees.